Profile | GDS4284 / 1567101_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 140.239 | 43 |
GSM687648 | Patient 402 control | 117.432 | 39 |
GSM687653 | Patient 403 control | 107.593 | 37 |
GSM687658 | Patient 404 control | 92.2858 | 33 |
GSM687663 | Patient 411 control | 148.253 | 41 |
GSM687668 | Patient 422 control | 78.3108 | 30 |
GSM687673 | Patient 424 control | 170.118 | 44 |
GSM687678 | Patient 425 control | 83.7476 | 30 |
GSM687683 | Patient 427 control | 157.463 | 41 |
GSM687688 | Patient 428 control | 76.2199 | 29 |
GSM687695 | Patient 441 control | 293.402 | 49 |
GSM687699 | Patient 443 control | 101.342 | 31 |
GSM687704 | Patient 444 control | 95.9475 | 34 |
GSM687707 | Patient 448 control | 165.165 | 40 |
GSM687712 | Patient 449 control | 130.837 | 39 |
GSM687719 | Patient 450 control | 140.939 | 37 |
GSM687724 | Patient 451 control | 143.335 | 39 |
GSM687728 | Patient 452 control | 255.328 | 52 |
GSM687646 | Patient 401 treated 24h | 116.381 | 37 |
GSM687649 | Patient 402 treated 24h | 67.6185 | 29 |
GSM687665 | Patient 411 treated 24h | 120.777 | 36 |
GSM687651 | Patient 402 treated 4 weeks | 181.833 | 45 |
GSM687667 | Patient 411 treated 4 weeks | 131.265 | 39 |
GSM687670 | Patient 422 treated 24h | 99.406 | 33 |
GSM687671 | Patient 422 treated 4 weeks | 107.121 | 37 |
GSM687654 | Patient 403 treated 24h | 88.9383 | 34 |
GSM687675 | Patient 424 treated 24h | 72.0973 | 26 |
GSM687685 | Patient 427 treated 24h | 166.781 | 44 |
GSM687656 | Patient 403 treated 4 weeks | 154.395 | 46 |
GSM687677 | Patient 424 treated 4 weeks | 107.976 | 36 |
GSM687687 | Patient 427 treated 4 weeks | 76.9184 | 32 |
GSM687692 | Patient 428 treated 4h | 88.2373 | 32 |
GSM687716 | Patient 449 treated 4h | 77.4402 | 30 |
GSM687722 | Patient 450 treated 4h | 149.16 | 39 |
GSM687680 | Patient 425 treated 24h | 153.705 | 43 |
GSM687690 | Patient 428 treated 24h | 73.7997 | 29 |
GSM687700 | Patient 443 treated 24h | 315.625 | 51 |
GSM687705 | Patient 444 treated 24h | 58.2767 | 26 |
GSM687714 | Patient 449 treated 24h | 107.526 | 37 |
GSM687721 | Patient 450 treated 24h | 166.937 | 40 |
GSM687682 | Patient 425 treated 4 weeks | 127.521 | 40 |
GSM687694 | Patient 428 treated 4 weeks | 145.801 | 44 |
GSM687702 | Patient 443 treated 4 weeks | 144.386 | 39 |
GSM687718 | Patient 449 treated 4 weeks | 206.663 | 49 |
GSM687723 | Patient 450 treated 4 weeks | 83.1011 | 30 |
GSM687661 | Patient 404 treated 4h | 78.9703 | 29 |
GSM687710 | Patient 448 treated 4h | 108.43 | 36 |
GSM687726 | Patient 451 treated 4h | 141.408 | 38 |
GSM687730 | Patient 452 treated 4h | 612.868 | 62 |
GSM687660 | Patient 404 treated 24h | 709.48 | 70 |
GSM687697 | Patient 441 treated 24h | 493.21 | 62 |
GSM687709 | Patient 448 treated 24h | 143.898 | 40 |
GSM687725 | Patient 451 treated 24h | 183.979 | 43 |
GSM687729 | Patient 452 treated 24h | 359.743 | 56 |
GSM687727 | Patient 451 treated 4 weeks | 150.647 | 39 |
GSM687731 | Patient 452 treated 4 weeks | 183.303 | 44 |